Afriag Global logo

AFRI - Afriag Global News Story

4.6p 0.1  2.2%

Last Trade - 11:02am

Micro Cap
Market Cap £1.43m
Enterprise Value £191k
Revenue £n/a
Position in Universe 1770th / 1814

AfriAg Global Plc: Disposal of African business and TVR

Fri 29th November, 2019 5:31pm
29 November 2019

AfriAg Global PLC

(‘AfriAg’ or the ‘Company’)

Disposal of African business and Total Voting Rights

AfriAg Global PLC (London NEX: AFRI) is pleased to announce that further to
its General Meeting held on 27 November 2019 at which meeting shareholder
approval was granted to proceed with the disposal of its subsidiaries, which
operates its African operations (the “Disposal”), it has completed the
Disposal. Following completion of the Disposal the Company holds no interest
in any subsidiary company save for its investments in Apollon Formularies
Limited and Tilray, Inc.

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure and
Transparency Rules, the Company hereby announces that it has 31,710,011
ordinary shares of no par value each in issue, each share carrying the right
to one vote.

This figure of 31,710,011 ordinary shares may be used by shareholders in the
Company as the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's Disclosure and
Transparency Rules.

The directors of the Company accept responsibility for the contents of this


For further information on AfriAg Global please visit the
or please contact;

AfriAg Global Plc:
David Lenigas (Executive Chairman)             +44 (0)20 7440 0640

Peterhouse Capital Limited         +44 (0)20 7469 0930
Guy Miller/ Allie Feuerlein

Copyright (c) 2019 PR Newswire Association,LLC. All Rights Reserved
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.